Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 200 of 3173 entries
View as:

Relative Bioavailability Of Palbociclib (PD-0332991) Under Fed And Fasted Conditions

Phase: N/A Priority: Normal
NCT ID: NCT02041273 Org: User:
Start: 01/31/14 End: 03/31/14 Due: 03/31/15

Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAP

Phase: N/A Priority: Normal
NCT ID: NCT02364284 Org: User:
Start: 02/28/15 End: 02/29/16 Due: 02/28/17

An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy

Phase: N/A Priority: Normal
NCT ID: NCT02907619 Org: User:
Start: 10/13/16 End: 11/22/18 Due: 11/22/19

A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT00150397 Org: User:
Start: 03/31/05 End: 11/30/05 Due: 11/30/06

A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00106639 Org: User:
Start: 05/31/05 End: 07/31/06 Due: 07/31/07

Safety and Pharmacokinetic Study of PF-06651600 in Japanese Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03232905 Org: User:
Start: 08/30/17 End: 11/22/17 Due: 11/22/18

A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01876251 Org: User:
Start: 11/04/13 End: 12/24/15 Due: 12/24/16

A Study of ARRY-520 in Patients With Advanced Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00637052 Org: User:
Start: 03/18/08 End: 06/21/10 Due: 06/21/11

Absorption, Metabolism, Excretion and Absolute Bioavailability

Phase: N/A Priority: Normal
NCT ID: NCT03250039 Org: User:
Start: 07/10/17 End: 09/15/17 Due: 09/15/18

A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis.

Phase: N/A Priority: Normal
NCT ID: NCT00787202 Org: User:
Start: 12/31/08 End: 09/30/10 Due: 09/30/11

AG-013736 In Combination With Gemcitabine Versus Gemcitabine Alone For Patients With Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00219557 Org: User:
Start: 07/05/05 End: 03/14/08 Due: 03/14/09

An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00939783 Org: User:
Start: 09/30/09 End: 08/31/10 Due: 08/31/11

A Study In Healthy People To Investigate The Safety, Toleration And Time Course Of Blood Concentrations Of Multiple Doses Of PF-03654764, Given By Mouth

Phase: N/A Priority: Normal
NCT ID: NCT00989391 Org: User:
Start: 10/31/09 End: 12/31/09 Due: 12/31/10

A Study Estimating The Time Course Of PF-04764793 In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers

Phase: N/A Priority: Normal
NCT ID: NCT00928278 Org: User:
Start: 07/31/09 End: 10/31/09 Due: 10/31/10

Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers

Phase: N/A Priority: Normal
NCT ID: NCT00318214 Org: User:
Start: 06/30/06 End: 02/29/08 Due: 02/28/09

A Study Evaluating Talazoparib in Relapsed Ovarian, Fallopian Tube, and Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02836028 Org: User:
Start: 10/31/16 End: - Due: -

A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)

Phase: N/A Priority: Normal
NCT ID: NCT01945775 Org: User:
Start: 10/14/13 End: 03/05/21 Due: 03/05/22

An Open Label Study To Evaluate The Safety and Kinetics of Nelfinavir in Subjects With HIV and Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT00141284 Org: User:
Start: 10/31/05 End: 12/31/06 Due: 12/31/07

Combining a Caregiver Intervention With Aricept Treatment for Mild to Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00467766 Org: User:
Start: 07/31/99 End: 06/30/03 Due: 06/30/04

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03709680 Org: User:
Start: 05/24/19 End: 10/18/25 Due: 10/18/26

A Study to Learn About Dacomitnib in Patients With Non-small Cell Lung Cancer Which Has Spread to the Brain.

Phase: N/A Priority: Normal
NCT ID: NCT06075615 Org: User:
Start: 09/30/24 End: 09/07/26 Due: 09/07/27

An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15)

Phase: N/A Priority: Normal
NCT ID: NCT05477524 Org: User:
Start: 08/04/22 End: 12/26/25 Due: 12/26/26

Rollover Protocol for Prior SU011248 Protocols

Phase: N/A Priority: Normal
NCT ID: NCT00798889 Org: User:
Start: 03/31/04 End: 12/31/11 Due: 12/31/12

A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Glasdegib

Phase: N/A Priority: Normal
NCT ID: NCT03627754 Org: User:
Start: 11/05/18 End: 04/11/19 Due: 04/11/20

Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT02461992 Org: User:
Start: 07/31/15 End: 08/31/15 Due: 08/31/16